European Summer School on Drug and Formulation Development
Description
European Summer School on Drug and Formulation Development (ESSDFD) is a three-day intensive course designed for students and pharmaceutical researchers. European Summer School on Drug and Formulation Development (ESSDFD) is a three-day intensive course designed for students and pharmaceutical researchers who wish to broaden their knowledge and advance in the career. The professionals, managers and investors who wish to gain deeper understanding of the complex process of drug development will also find this course very beneficial. The aim of ESSDFD is to provide relaxed but stimulating environment for students and other participants to attend the lectures, to establish a long-term relationship among participants and to encourage the vigorous and fruitful interactions and discussions.
ESSDFD-2 addresses all aspects of a complex process of advancing a successful drug candidate to the pre-clinical trials and eventually to the market. Both traditional and modern approaches to drug formulation development and corresponding methodologies will also be covered. ESSDFD will provide approximately 20 hours of lectures by world-leading experts from both industrial and academic settings. Program will be roughly subdivided into drug development and drug formulation sessions and it will include virtually all topics of relevance to the drug and formulaion development:
- Pharmaceutical development: structure, environment and paradigms
- CMC of pharmaceutical development
- ADME/DPMK, pharmacokinetics and toxicology
- Patent protection and regulatory affairs
- Pharmacogenomics.
- Rational vs. empirical approach to the formulation development
- Product development challenges and strategies
- Choosing the optimal dosage form and routes of administration
- The importance of choosing the optimal solid form of drug. Polymorphs and solvates
- Chemical stability of drug in solid state and in solution
- Physico-chemical and biopharmaceutical profiling. Biopharmaceutical classification system, ionization, lipophilicity, solubility
- Drug absorption and permeability
- Strategies for the development of formulations of poorly soluble drugs
- Excipients and their compatibility
- Formulation development of peptides and proteins
- Analytical methodologies in the formulation development
Tell your friends
RECENT FACEBOOK POSTS
facebook.comHOME
The 10th Joint Meeting on Medicinal Chemistry will be organized by the Medicinal Chemistry Section of the Croatian Chemical Society and sponsored by the European Federation for Medicinal Chemistry. It will be held on June 25–28, 2017 in Dubrovnik (Srebreno), Croatia. http://www.jmmc2017.hr/index.php
The 2016 Nobel Prize in Chemistry - Press Release
Timeline Photos
5th IAPC Meeting: Emerging Technologies in Drug Discovery and Development Zhuhai, PR China, August 23-26, 2016 PROGRAM Monday, August 22, 2016 15:00 – 19:00 Participant registration / Poster mounting 19:30 – Welcome party – Dehan hotel Tuesday, August 23, 2016 08:00 – 08:30 Participant registration / Poster mounting 08:30 – 08:45 Opening ceremony Session 1. Recent advances in the physico-chemical/activity profiling of drug substances Chairperson Alex Avdeef 08:45 – 09:30 OP 01 Jin Li, Hitgen Ltd., China Finding Needles in Very Large Haystacks: DNA-Encoded Libraries (Dels) for Lead Generation 09:30 – 10:15 OP 02 Godefridus J. Peters, VU University Medical Center, The Netherlands Role of Physico-Chemical and ADME Properties in Cancer Drug development 10:15 – 10:45 Coffee break / Poster session Chairperson Godefridus Peters 10:45 – 11:30 OP 03 Kwok-Yin Wong, The Hong Kong Polytechnic University, China Development of Fluorescent Biosensors for Screening of Inhibitors of Some Bacterial Enzymes 11:30 – 12:15 OP 04 Wei Gao, Tonglei Li, Purdue University, USA Development of Drug Nanocrystals for Theranostics 12:15 – 12:40 OP 05 Caroline Alvebratt, Erik Petersson, Maria Strömme, Christel A.S. Bergström, Uppsala University, Sweden A Small Scale Method to Determine Release Rate from Complex Carrier-Mediated Systems Lunch Session 2. Recent advances in solid state characterization Chairperson Elena Boldyreva 14:30 – 15:15 OP 06 Rolf Hilfiker, Solvias AG, Switerland Impact of Polymorphism on the Development and Manufacturing of Pharmaceuticals 15:15 – 16:00 OP 07 Alex Avdeef, in-ADME Research, USA Cocrystal Solubility-pH Data Analysis using pDISOL-X (with Automatic Equilibrium Equation Generation) 16:00 – 16:20 OP 08 Shichao Du, Yan Wang, Jingkang Wang, Junbo Gong, Tianjin University, China Two Novel Cocrystals with Improved Solubility and In Situ Monitoring of Cocrystallization of Lamotrigine 16:20 – 16:50 Coffee break / Poster session Chairperson Rolf Hilfiker 16:50 – 17:35 OP 09 Elena Boldyreva, Novosibirsk State University, Russia Drugs as Materials: Processing, Structure, Properties 17:35 – 18:05 OP 10 Marzena Rams-Baron, Żaneta Wojnarowska, Mateusz Dulski, Patryk Włodarczyk, Marian Paluch, University of Silesia, Poland The Importance of Proton Transfer in Amorphous Active Pharmaceutical Ingredients 18:05 – 18:30 OP 11 Khadijah Edueng; Denny Mahlin; Christel Bergström, Uppsala University, Sweden Mechanism-Based Selection of Stabilization Strategy for Amorphous Formulation 19:30 - Conference dinner / Dehan hotel Wednesday, August 24, 2016 Session 3. Recent advances in drug discovery Chairperson Chia-Ning Shen 08:30 – 09:15 OP 12 Hong Wan, Shanghai Hengrui Pharmaceutical CO., Ltd, China Discovery and Development of Pyrotinib: A Novel Irreversible EGFR/HER2 Dual Tyrosine Kinase Inhibitor with Favorable Safety Profiles for the Treatment of Breast Cancer 09:15 – 09:45 OP 13 Lihua Tan, Cailan Li, Hanbin Chen, Zhizhun Mo, Jiangtao Zhou, Yuhong Liu, Zhilin Ma, Yuyao Xu, Xiaobo Yang, and Jianhui Xie, Ziren Su, Guangzhou University of Chinese Medicine, China Epiberberine, a Natural Protoberberine Alkaloid, Inhibit Urease of Helicobacter pylori and Jack Bean via Binding to the Sulfhydryl Groups 09:45 – 10:15 OP 14 Wen Zhang, Xiaohui Hu, Shao-Lin Zhang, Kin Yip Tam, University of Macau Phenyl Butyrate Inhibits Pyruvate Dehydrogenase Kinase 1 and Contributes to its Anti-Cancer Effects 10:15 – 10:45 Coffee break / Poster session Chairperson Hong Wan 10:45 – 11:30 OP 15 Tao Chen, Bo Jiang, Yuan Xu, Feng Zhi, Yiling Yang, Ying Xia, The University of Texas McGovern Medical School, USA A Potential Target for Parkinsonism Treatment 11:30 – 12:15 OP 16 Wen-Ying Liao, Chih-Chuang Liaw, Chien-Shu Chen, Sheng-Chu Kuo, Yuan-Chao Huang, and Chia-Ning Shen, Genomics Research Center, Academia Sinica, Taiwan Excessive Porphyrin Production Induced by Cyclohexylmethyl Flavonoids Suppresses Self-Renewal Propagation of Breast Cancer Stem Cells 12:15 – 12:40 OP 17 Li Yang, Zhongyan Wang, Huiling Zhang, Wei Xu, Shuxing Zheng, Haiyong Zhang, Yin Tian, Chong Qing, University of Posts and Telecommunications, China Predictors for drug effects with Alzheimer’s disease: shed new light from EEG parameters to brain connectomics Lunch Session 4. Recent advances in computational methods/ odelling, biophysical and ana¬lytical techniques of importance in medicinal chemistry and pharmaceutical research Chairperson Abu Serajuddin 14:30 – 15:15 OP 18 Alex Avdeef, in-ADME Research, USA Data Mining for Equilibrium Solubility of Ionizable Druglike Molecules 15:15 – 16:00 OP 19 Klara Valko, Bio-Mimetic Chromatography, UK How to Optimize the Physicochemical and Biomimetic Properties of Putative Drug Molecules? 16:00 – 16:30 OP 20 Mare Oja, Uko Maran, University of Tartu, Estonia Comparison and Modelling of Experimental and Calculated Distribution Coefficient (Logd) Values at Various pHs 16:30 – 17:00 Coffee break / Poster session Chairperson Kiyohiko Sugano 17:00 – 17:35 OP 21 Muhammad Arba, Rahmad Sutrisna, Ruslin, Universitas Halu Oleo, Indonesia Quantitative Structure Activity Relationship (QSAR) Analysis of Indirubin DerivativesaAs Cyclin Dependent Kinase 5 (CDK5) Inhibitor 17:35 – 18:10 OP 22 Ruslin, Rahmad Sutrisna, Muhammad Arba, Universitas Halu Oleo, Indonesia Design and Molecular Docking Study of Novel Indirubin Derivatives as Inhibitor of Cyclin Dependent Kinase 5 (CDK5) 18:10 – 18:30 Poster dismounting Thursday, August 25, 2016 Session 5. Recent advances in drug development Chairperson Tonglei Li 09:00 – 09:45 OP 23 Abu T. M. Serajuddin, St. John’s University, USA Strategies for the Development of Liquid, Semisolid and Solid Lipid-Based Drug Delivery Systems 09:45 – 10:30 OP 24 Marian Paluch and Justyna Knapik, University of Silesia, Poland Study on Effective Methods for Stabilizing the Amorphous Forms of Anti-Cholesterol Drug: Ezetimibe 10:30 – 11:00 Coffee break Chairperson Klara Valko 11:00 – 11:45 OP 25 Kiyhiko Sugano, Toho University, Japan Theoretical Investigation on Bioequivalence and Biowaiver Scheme 11:45 – 12:30 OP 26 Shun Ming Yuen, Jie Ye, Gillian Murphy, Ruiyu Xie and Hang Fai Kwok, University of Macau, Macau Anti-Tumour Effects of a Human and Mouse Cross-Reactive’ Anti-TACE Antibody in a Pancreatic Cancer Model In Vivo 12:30 Conference closing 14:00 Optional excursion: Zhuhai sightseeing tour and dinner
Timeline Photos
5th IAPC Meeting, August 26, 2016, Zhuhai, P.R. China Short Introduction in Drug Development Post-conference course Abu Serajuddin Transforming New Molecular Entities into Drug Products Structure of Pharmaceutical Research and Different Paradigms of Drug and Formulation Development in the Pharmaceutical Industry Alex Avdeef Balance between Passive & Carrier-Mediated Uptake in Drug Disposition Abu Serajuddin Biopharmaceutical Roadmap (BioRam) strategy: Development of Advanced Delivery Systems to Address Patient Needs and for Better Therapy Rolf Hilfiker The Importance of Choosing the Optimal Solid Form of a Drug: Salts, Co-Crystals, Polymorphs, Amorphous, Solvates
3rd European Summer School on Drug and Formulation Development (ESSDFD-3) Zagreb, Croatia, September 2017
Vol 6, No 2 (2016)
New Issue: Vol 6, No 2 (2016) Table of Contents Electrochemical Science Spectroscopic, voltammetry and molecular docking study of binding interaction of antipsychotic drug with bovine serum albumin Mallappa Mahanthappa, Babu Giriya Gowda, Jayant I. Gowda, Raghavendran Rengaswamy Oxygen source-Oriented Control of APCVD VO2 for Capacitive Applications Dimitra Vernardou, Antonia Bei, Dimitris Louloudakis, Nikolaos Katsarakis, Emmanouil Koudoumas Anticorrosive behaviour of lumefantrine hydrophobic layer on mild steel surface Pavithra M. Krishnegowda, Venkateha T. Venkatarangaiah, Punith Kumar M. Krishnegowda, Anantha N. Subba Rao, Shubha H. Nataraj Etoricoxib selective sensor based on Uracil-5,6-diamino-2-thio hydrochloride UDTHas neutral carrier for potentiometric analysis in Pharmaceutical Preparations Salwa Fares Rassi Electrocoagulation removal of anthraquinone dye Alizarin Red S from aqueous solution using aluminum electrodes: kinetics, isothermal and thermodynamics studies Abideen Idowu Adeogun, Ramesh Babu Balakrishnan http://pub.iapchem.org/ojs/index.php/JESE/issue/current
IAPC-5 meeting
We would like to draw your attention to the 5 th IAPC Meeting: Emerging Technologies in Drug Discovery and Development incorporating World Conference on ADMET and DMPK (ADMET-2) & 5th World Conference on Physico Chemical Methods in Drug Discovery and Development (PCMDDD-5 ) which will take place as a joint event in Zhuhai Dehan Hotel, Zhuhai, China from August 23-26, 2016. The conference is organized by International Association of Physical Chemists. You can find more information at the conference website. http://www.iapchem.org/page.php?page_id=71 This three-day event will cover recent achievements in the methodologies used in successful drug candidate identification and development. Determination of ADME/Tox properties through the in vitro and in vivo assays will be discussed. The particular attention will be paid to the evaluation and improvement of critical drug parameters which determine the fate of the drug, from its administration over its remedial action to its excretion. Accompanying Short introduction in drug development course will take place as a post-event to the main conference.(http://www.iapchem.org/page.php?page_id=81) Abstract submission deadline: June 15, 2016. Full paper suggestion deadline: August 01, 2016. For more information visit this page: http://www.iapchem.org/page.php?page_id=82 . We really do hope you will be able to participate at this exciting event. Beside the conference program of high scientific level and prominent speakers, the Conference organizer will do its best to turn your participation into the unforgettable event.
Vol 5, No 4 (2015)
jESE - New Issue Vol 5, No 4 December 2015 http://pub.iapchem.org/ojs/index.php/JESE/issue/view/35
Research in Germany
Research in Germany
Royal Society of Chemistry Early Careers Symposium
Home - 17th Tetrahedron Symposium
17th Tetrahedron Symposium Challenges in Biological, Bioorganic, Organic & Medicinal Chemistry 28 June - 1 July 2016 | Sitges (near Barcelona), Spain http://www.tetrahedron-symposium.elsevier.com/
Quiz
